Lv1
80 积分 2025-09-24 加入
Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective
5个月前
已完结
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton’s Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies
7个月前
已完结